Latest Dopamine agonists Stories
Data Showed Reduced Nocturnal Systolic Blood Pressure Elevations and Periodic Limb Movements During Sleep in Restless Legs Syndrome (RLS) Patients ATLANTA, May 17, 2013 /PRNewswire/ -- UCB today announced data from a double-blind, placebo-controlled study that found that Neupro(®) (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure (NSBP) elevations associated with periodic limb movements during sleep (PLMS) and total PLMS in patients with idiopathic...
Delray Recovery Center is Florida facility that offers individual treatment plans for drug addiction, alcohol addiction, eating disorders and co-occurring disorders including depression, anxiety and bipolar disorder. The center is releasing a new infographic on the dangers of bath salt abuse, which is becoming an increasing problem throughout the U.S. Delray Beach, FL (PRWEB) April 04, 2013 Bath salts can cause heart attacks, stroke, swelling of the brain, coma and death, according to the...
Data from a non-interventional, observational study of 76 patients presented at the 65th American Academy of Neurology Annual Meeting ATLANTA, March 19, 2013 /PRNewswire/ -- UCB today announced data from a non-interventional, observational study conducted in Germany that found that when Parkinson's disease (PD) patients were switched from an oral PD medication to Neupro(®) (Rotigotine Transdermal System), they reported improvements in pre-existing gastrointestinal (GI) symptoms....
Marijuana Remains Most Commonly Detected; Oral Fluid Finding More Positives MADISON, N.J., March 7, 2013 /PRNewswire/ -- Job candidates subject to pre-employment drug screening tested positive for illicit drugs at a greater rate in the first six months of 2012 than in all of 2011, according to Drug Testing Index(TM) (DTI) data released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. The positivity rate from pre-employment...
Alan McStravick for redOrbit.com - Your Universe Online Addiction is a serious disorder of the brain that is characterized by a chronic and compulsive need to take a substance, typically with an increase in dosage and frequency. Someone suffering from addiction will continue their behavior even in the face of negative consequences. The root cause of addiction is not specifically known, however. A new study out of the University of Texas at Austin (UT) may just point to one indicator of...
ATLANTA, Dec. 5, 2012 /PRNewswire/ -- Health expert and patient advocate Dr. Donnica Moore and global biopharmaceutical company UCB, Inc. are launching Choose Your Move: Take Control of RLS to shed light on the real impact of Restless Legs Syndrome (RLS) and empower those living with the disease to work with their doctor to find a treatment approach that's right for them. "Unfortunately, many people do not fully understand what it's like to live with the disease," says Dr. Moore....
ROCHESTER, Minn., Sept. 20, 2012 /PRNewswire-USNewswire/ -- For far too many people, the symptoms are all-too familiar: uncomfortable, even painful, sensations in the legs while at rest. Tingling, twitching, throbbing or "antsy" feelings in the calves or thighs and even arms that make you want to get up, stretch, and move around. While these sensations can be hard to describe, the diagnosis isn't. It's called Restless Legs Syndrome (RLS/WED, or Willis-Ekbom disease) - and it affects...
Advantage Testing in Beaumont, Texas educates consumers on the dangers and laws regarding a new synthetic drug with the street name "Bath Salts" and advises employers that the company now provides testing for this illegal substance. (PRWEB) September 08, 2012 Advantage Testing, a leading provider of workplace drug testing in Beaumont, Texas, recently decided to create awareness about the use of a fairly new synthetic drug that goes by the street name "Bath Salts." In...
BRUSSELS and ATLANTA, July 16, 2012 /PRNewswire/ -- UCB announced today that Neupro(®) (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro(®) was approved by the U.S Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome. Neupro(®) improves motor function and activities of daily living in patients with PD and provides...
MORRISTOWN, N.J., June 25, 2012 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it has received approval from the US Food & Drug Administration to market Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules CII, (hereafter referred to as Mixed Amphetamine Salts ER Capsules), in all available strengths: 5mg, 10mg, 15mg, 20mg, 25mg, and...
